DEV — Deversify Health AB (publ) Balance Sheet
0.000.00%
- SEK12.78m
- SEK12.77m
- SEK18.66m
Annual balance sheet for Deversify Health AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | ARS | ARS | ARS | Interim Report |
Standards: | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Short Term Investments | 0.807 | 12.2 | 4.81 | 2.29 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 4.13 | 4.29 | 3.56 | 3.04 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Current Assets | 5.11 | 17.3 | 9.52 | 5.81 |
Net Property, Plant And Equipment | — | 0.114 | 0.144 | 0 |
Net Goodwill | ||||
Net Intangible Assets | ||||
Long Term Investments | ||||
Long Term Notes Receivable | ||||
Total Assets | 9.08 | 50.1 | 36.4 | 15.8 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 8.42 | 14.9 | 12.6 | 8.36 |
Total Long Term Debt | ||||
Total Debt | ||||
Minority Interest | ||||
Total Other Liabilities | ||||
Total Liabilities | 8.42 | 16 | 15.4 | 15.5 |
Common Stock | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 0.662 | 34.1 | 21 | 0.278 |
Total Liabilities & Shareholders' Equity | 9.08 | 50.1 | 36.4 | 15.8 |
Total Common Shares Outstanding |